Kiniksa Pharmaceuticals, Ltd. — Form D/A

Kiniksa Pharmaceuticals, Ltd. of Hamilton, D0, a company, filed a Form D amendment with the SEC on 2019-07-11. The offering totals $7.5M, of which $7.5M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (21)

NameRoleLocation
CHRIS K HEBERLIGExecutive OfficerHAMILTON, D0
RICHARD S LEVYDirectorHAMILTON, D0
RICHARD S LEVYRelated PersonHAMILTON, D0
STEPHEN R BIGGARDirectorHAMILTON, D0
STEPHEN R BIGGARRelated PersonHAMILTON, D0
FELIX J BAKERDirectorHAMILTON, D0
FELIX J BAKERRelated PersonHAMILTON, D0
THOMAS W BEETHAMExecutive OfficerHAMILTON, D0
SANJ K PATELDirectorHAMILTON, D0
SANJ K PATELExecutive OfficerHAMILTON, D0
SANJ K PATELRelated PersonHAMILTON, D0
THOMAS R MALLEYDirectorHAMILTON, D0
THOMAS R MALLEYRelated PersonHAMILTON, D0
G. BRADLY D COLEDirectorHAMILTON, D0
BARRY D QUARTDirectorHAMILTON, D0
BARRY D QUARTRelated PersonHAMILTON, D0
KIMBERLY J POPOVITSDirectorHAMILTON, D0
KIMBERLY J POPOVITSRelated PersonHAMILTON, D0
TRACEY L MCCAINDirectorHAMILTON, D0
TRACEY L MCCAINRelated PersonHAMILTON, D0
CHRIS HEBERLIGRelated PersonHAMILTON, D0

Other filings by this issuer (2)

FiledFormOfferingSold
2020-11-23D/A$8.8M$8.8M
2019-04-04D$5.9M$5.9M

More